| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.0021 | 0.9 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.0087 | 1 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0053 | 1 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |